1-4 of 4
Gottfried Dölken, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Sequential High Dose Immuno-Chemotherapy Followed by Autologous Peripheral Blood Stem Cell Transplantation for Patients with Untreated Primary Central Nervous System Lymphoma - a Multicentre Study by the Collaborative PCNSL Study Group Freiburg

Gerald Illerhaus, MD, Kristina Fritsch, MD, Gerlinde Egerer, MD, Monika Lamprecht, MD, Nikolas von Bubnoff, MD, Hans-Heinrich Wolf, MD, Gottfried Dölken, MD, Stephan Stilgenbauer, MD, Jens Panse, MD, Stefan Balabanov, MD, PhD, Peter Hau, MD, Norbert Frickhofen, MD, Martin Bentz, MD, Alexander Roeth, MD, Robert Möhle, MD, Tobias Birnbaum, MD, Michael Pfreundschuh, MD, Claudia Hader, MD, Gabriele Ihorst, Martina Deckert, MD, Marco Prinz, MD, Elisabeth Schorb, MD, Heidi Fricker, Benjamin Kasenda, MD, Jürgen Finke, MD
Journal: Blood
Blood (2012) 120 (21): 302.
https://doi.org/10.1182/blood.V120.21.302.302
Published: 2012
Journal Articles

A Therapeutic Platelet Transfusion Strategy without Routine Prophylactic Transfusion Is Feasible and Safe and Reduces Platelet Transfusion Numbers Significantly: Preliminary Analysis of a Randomized Study in Patients after High Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation

Hannes Wandt, MD, Knut Wendelin, MD, Kerstin Schaefer-Eckart, MD, Markus Thalheimer, MD, Mario Stephan Schubert, MD, Roland Conradi, MD, Rainer Schwerdtfeger, MD, Lothar Leimer, MD, Martin Kaufmann, MD, Gottfried Dölken, MD, Anne Friederike Klenner, MD, Markus Schaich, MD, Gerhard Ehninger, MD
Journal: Blood
Blood (2008) 112 (11): 286.
https://doi.org/10.1182/blood.V112.11.286.286
Published: 2008
Journal Articles

Increased Leukaemia Free Survival (LFS) in Patients with Cytogenetic High Risk AML after Related or Unrelated Hematopoietic Cell Transplantation (HCT) Compared to Chemotherapy in the OSHO 96 and 2002 Studies.

Dietger Niederwieser, MD, Cornelia Becker, MD, Rainer Krahl, Ph.D., Haifa-Kathrin Al-Ali, MD, Simone Heyn, MD, Michael Cross, Ph.D., Thoralf Lange, MD, Anke Gerhardt, MD, Antje Schulze, MD, Detleff Haehling, MD, Manfred Schulze, MD, Matthias Freund, MD, Erika Kettner, MD, Gottfried Dölken, MD, Michael Assmann, MD, Hans-Heinrich Wolf, MD, Ernst Zschuppe, MD, Norma Peter, MD, Astrid Franke, MD, Ulrich Wedding, MD, Lutz Uharek, MD, Ute Kreibich, MD, Norbert Grobe, MD, Thomas Ittel, MD, Axel Florschuetz, MD, Bernd Opitz, MD, Karin Senftleben, MD, Veronika Schirmer, MD, Friedrich Fiedler, MD, Renate Huhn, MD, Werner Helbig, MD
Journal: Blood
Blood (2006) 108 (11): 264.
https://doi.org/10.1182/blood.V108.11.264.264
Published: 2006
Journal Articles

Results of a Prospective Randomised Open Label Phase III Study Comparing Rituximab Plus Mitoxantrone, Chlorambucile, Prednisolone Chemotherapy (R-MCP) Versus MCP Alone in Untreated Advanced Indolent Non-Hodgkin’s Lymphoma (NHL) and Mantle-Cell-Lymphoma (MCL).

Michael Herold, MD, Rita Pasold, MD, Stefanie Srock, MD, Sabine Neser, MD, Dietger Niederwieser, MD, Andreas Neubauer, MD, Gottfried Dölken, MD, Ralph Naumann, MD, Thomas Fietz, MD, Mathias Freund, MD, Robert Rohrberg, MD, Klaus Hoeffken, MD, Astrid Franke, MD, Thomas H. Ittel, MD, Erika Kettner, MD, Ursula Haak, MD, Ullrich Mey, MD, Christian Klinkenstein, MD, Michael Assmann, MD, Ullrich von Gruenhagen, MD, Klaus Dachselt, MD, Helga Schwenke, MD, Dorothee Bleyl, MD, Heiner Wolf, MD, Sabine Hahnfeld, MD, Franz-Adolph Hoffmann, MD, Volker Lakner, MD, Peter Richter, MD, Detlev Hähling, MD, H. H. Wolf, MD, Henning Eschenburg, MD, M.-R. Clemens, MD, Norbert Grobe, MD
Journal: Blood
Blood (2004) 104 (11): 584.
https://doi.org/10.1182/blood.V104.11.584.584
Published: 2004